Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
about
Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic ReviewProstate cancer in Brazil and Latin America: epidemiology and screeningProstate-specific antigen and perfluoroalkyl acids in the C8 health study populationThe effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.Prostate cancer screening: a complicated puzzle, explanation neededImpact of patient navigation on timely cancer care: the Patient Navigation Research ProgramThe high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era.Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.Prostate-specific antigen screening in prostate cancer: perspectives on the evidenceRecommendations on screening for prostate cancer with the prostate-specific antigen test.Expected population impacts of discontinued prostate-specific antigen screening.Latino men and familial risk communication about prostate cancer.Determinants of participation in prostate cancer screening: a simple analytical framework to account for healthy-user bias.Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.Prostate-specific antigen-based screening: controversy and guidelinesA simple schema for informed decision making about prostate cancer screening.A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings.The pace of change in medical practice and health policy: collision or coexistence?Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.Eliciting women's cervical screening preferences: a mixed methods systematic review protocolDevelopment and Validation of a 10-Year Mortality Prediction Model: Meta-Analysis of Individual Participant Data From Five Cohorts of Older Adults in Developed and Developing Countries.Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer.Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment StrategiesIncidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide.Knowledge and practice of prostate cancer screening among general practitioners in Malaysia: a cross-sectional study.Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter.Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression.Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.MRI in prostate cancer.Prostate cancer: measuring PSA.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Prostate-specific antigen-based prostate cancer screening: Past and future.Epithelial-mesenchymal transition in prostatic disease.The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.Engaging Stakeholders to Inform Clinical Practice Guidelines That Address Multiple Chronic Conditions.Prostate cancer screening practices in a large, integrated health system: 2007-2014.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.What's new in screening in 2015?
P2860
Q26748873-A9835B73-3701-41DA-9B1A-91614D46F3C9Q28079012-5989BAC4-023D-4022-9B4A-66C8AE4B8581Q28384774-78CFDD7F-E84F-4181-AC48-6C2DE4B2D946Q30239973-59C095AE-B20A-4096-A218-92CD0C033622Q33356114-94F34453-67A9-4032-A39F-84218790F082Q33813179-7DEE47DF-B5C9-4F68-AD8F-A455014D640FQ34042937-70BAF57F-1CF2-4EAB-A63C-D24DCFDD4460Q34159375-D2676975-CCC1-4943-A597-EE92D0E36EEAQ34354430-99665BD7-8E1C-485F-A75A-8FC80A182832Q34435885-8FF09CFC-5539-4DCB-AD8D-61DC8D22AFBAQ34458237-81DD0163-0FD5-4D76-A769-902D2AE041E2Q34702276-5760C901-F21E-437C-98E3-1CF09CCED31CQ35051353-A88B13B4-ED2C-49DA-90FC-7CDA67C8ED54Q35204021-FA2F5D37-BBF1-48DC-B760-05EA183890DFQ35211931-6ED87D33-F9F3-43C3-AAB2-B0962CD57248Q35546777-1124293D-BD3D-4AD3-9E26-55B5F29420BAQ35638183-155A8D8B-38FB-4719-AD8D-C5248D63F7EDQ35638254-5BACC57A-6CD1-4F4C-B877-7348312FA0EDQ35954487-26361CB1-A9F6-49E6-8AC2-9FFCF2A4402EQ36102272-209D9C8F-D112-4525-95B2-50AF2C1BE9BBQ36103607-8C049850-49EA-48FC-853D-FB97372C6CE4Q36114762-A70C30BE-831E-440A-AE15-E58275013BABQ37095655-2A4CBFC1-BDF5-453B-9A6C-7EA252D78ECBQ37273869-4DF00C87-6913-464D-9F98-A352182978F7Q37312608-7EBA2F5E-4DB8-4C37-A8ED-5786223C67A8Q37393072-3C7E9CD0-3B9A-458F-B0CC-936D7BB3F481Q37400784-B5619049-6BEE-408B-8859-CF94FDD3B5B2Q37746702-1F1F5B3F-9B82-441E-8049-D6084C4BBBD6Q38201469-5F82FA6A-A78D-4201-9A5C-86D6A88A7C04Q38210857-835334F6-9434-4580-B34D-4F81BCAB1A8EQ38216129-B22148B6-82FD-4618-BB18-473DFDE93537Q38408501-50234E4C-44B6-4507-A2AA-D3D87A151ADBQ38628753-7869DA40-FA7C-4B24-B7F1-9B7A29992617Q38684598-DB3FAC01-7746-4859-8111-ACA47441550CQ38716380-1DC6F8A2-290B-46E9-82B0-A390C30FB3F7Q38723029-2466CD50-C529-4558-AF29-8B00D958D1B5Q38738730-E906BD73-F598-4953-B90B-A693177AE62EQ38764041-ABC1DE36-0987-43F1-8969-0B8108212170Q38777365-FD08BE54-ED51-43C8-80FE-248EECBE5469Q38871819-B5A31F81-61CC-4E6D-9BE8-139443B68F88
P2860
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Screening for prostate cancer: ...... merican College of Physicians.
@ast
Screening for prostate cancer: ...... merican College of Physicians.
@en
Screening for prostate cancer: ...... merican College of Physicians.
@nl
type
label
Screening for prostate cancer: ...... merican College of Physicians.
@ast
Screening for prostate cancer: ...... merican College of Physicians.
@en
Screening for prostate cancer: ...... merican College of Physicians.
@nl
prefLabel
Screening for prostate cancer: ...... merican College of Physicians.
@ast
Screening for prostate cancer: ...... merican College of Physicians.
@en
Screening for prostate cancer: ...... merican College of Physicians.
@nl
P2093
P1476
Screening for prostate cancer: ...... merican College of Physicians.
@en
P2093
Amir Qaseem
Clinical Guidelines Committee of the American College of Physicians
Douglas K Owens
Michael J Barry
Paul Shekelle
Thomas D Denberg
P304
P356
10.7326/0003-4819-158-10-201305210-00633
P407
P577
2013-05-01T00:00:00Z